HOME >> MEDICINE >> NEWS
Rice nanophotonics lab gets $3 million training grant

HOUSTON, July 12, 2005 Rice University's Laboratory for Nanophotonics (LANP) has been awarded a highly competitive, five-year, $3 million federal grant for a program to prepare students in the design and fabrication of nanoscale optical components and their applications in emerging technologies.

Nanophotonics, the development of new ways to generate and manipulate light using ultrasmall, engineered structures -- some as tiny as a strand of DNA -- is one of the fastest growing fields in nanotechnology. Nanophotonics spans the disciplines of physics, chemistry, electrical engineering and bioengineering, and it holds promise for important technological advances in industries as diverse as microelectronics, magnetic recording, biomedicine, environmental remediation and homeland security.

The purpose of the training program is to create leaders with the technical and professional skills needed to achieve research breakthroughs in this emerging area and to apply them to a broad range of advanced technologies. The grant was awarded by one of the National Science Foundation's (NSF) most competitive programs, the Integrative Graduate Education and Research Training (IGERT) program.

"Rice has long been known for cross-cutting interdisciplinary research in emerging fields such as biomedicine, information technology and nanotechnology," said LANP Director Naomi Halas, the Stanley C. Moore Professor of Electrical and Computer Engineering and professor of chemistry. "Nanophotonics is proving to be a highly valuable new approach in advancing all these technologies. Our nanophotonics program includes leading theorists and experimentalists in both the basic and applied sciences, and the IGERT award recognizes that we have one of the nation's top programs."

A major focus of Rice's program is graduate training in the design, fabrication, and use of nanoscale optical components that are compatible with living systems. Key program elements include a core
'"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
12-Jul-2005


Page: 1 2 3

Related medicine news :

1. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
2. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
3. FPG receives $8 million for autism research
4. CIRM awards $3.79 million to Burnham Institute
5. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
6. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
7. Mayor of New York proposes preventing 100 million deaths from tobacco
8. Menzies School of Health Research receives $5.3 million in Federal Budget
9. $30 million boost to dementia research
10. $1.5 million awarded for palliative care research
11. $7.5 million NIH grant to Yale for Autism Center of Excellence

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rice nanophotonics lab gets million training grant

(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together ... by up to 30lbs in less than 12 weeks without ... Stevenson, prompting an investigative review. , “Our Incredible Bulk ... formula that allows the body to pack on a massive ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: